MedicaBazaar

Get Quotation

Add To Favorites

Compare This Product

Description

Inflammatory disease test kit
IF 1003

Getein Biotech Inc.

Characteristics

analysis mode	immunoassay, immunofluorescence
applications	for inflammatory diseases
sample type	serum, whole blood, plasma
tested parameters	CRP
Result display time	3 min

Description

hs-CRP+CRP Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of C-reactive protein (CRP) in serum, plasma whole blood, or fingertip blood. Measurement of CRP is useful for the detection and evaluation of infection, tissue injury and inflammatory disorders. Measurement of high sensitivity CRP (hs-CRP), when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes (ACS), may be useful as an independent marker of prognosis for recurrent events in patients with stable coronary disease or ACS.

About hs-CRP+CRP
C-reactive protein is an acute-phase reactant that precipitated with Pneumococcal C-polysaccharide, and is a non-specific immune response component. CRP has wide distribution in our body, and is an acute-phase protein produced in the liver in response to microbic infection or tissue injury, it measures general levels of inflammation in the body, and the hs-CRP can be used to detect lower concentrations of CRP in serum or plasma. Studies revealed hs-CRP levels seem to be correlated with Atherosclerosis and Acute Myocardial Infarction. And the hs-CRP is an inflammation \"marker\" for ACS patient and is helpful for primary prevention and risk assessment of cardiovascular disease. Its combination with the ratio of total cholesterol to HDL-C is more accurate than other risk factor in predicting cardiovascular disease.

Contents
1. For Getein1100
Package specifications: 25 tests/box, 10 tests/box
1) hs-CRP+CRP test card in a sealed pouch with desiccant
2) Capillary pipet
3) Sample diluent
4) User manual: 1 piece/box
5) SD/RFID card: 1 piece/box

Getein Biotech Inc.

Follow Contact

0 Followers

Request a Meeting

About the Company

Getein Biotech, Inc. (stock code:603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT). In July 2017, Getein Biotech got listed on the main board of the Shanghai Stock Exchange.
As a biotechnical company, Getein Biotech has been dedicated to providing excellent in vitro diagnostic service for people from all over the world with our most advanced technology. With great contribution of our advanced R&D center and 19-year continuous development, Getein Biotech has developed 8 technology platforms, including Point-Of-Care Testing (POCT), clinical chemistry, chemiluminescence, hematology, coagulation, urinalysis, molecular diagnostics and raw materials for diagnostic reagents, covering testing fields of cardiovascular disease, kidney injury, diabetes mellitus, gestation, infectious disease, cancer, etc.. Meanwhile, Getein Biotech achieved BSI ISO13485 Quality Management System Certification and CE Certification, ensuring good quality, stability and reliability of the products.
At present, Getein Biotech owns 35 subsidiaries and our business has developed to over 110 countries and regions of all over the world. The market share of Getein Biotech keeps in the first rank in the cardiac POCT market in China. And currently, we serve over 30,000 hospitals in China and countless hospitals in the world.
Taking people's wellbeing as the motivation of our continuous development, Getein Biotech is dedicated to becoming an international competitive biological technological company and contributes to people's health in the world. That’s our commitment to helping people from different countries live a happy and well life.

Our mission to "pursue excellence and deliver health” means a commitment to keep patients’ wellbeing in mind. We strive to deliver high-quality, reliable, and affordable point-of-care and diagnostic solutions to professional clinical laboratories, hospitals, and physician offices. Our commitment is backed by our quality first policy, talented team, innovative technology and accountability attitude.

Products